Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-25 @ 4:16 AM
NCT ID:
NCT00004420
Eligibility Criteria:
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
* Juvenile rheumatoid arthritis (systemic onset, pauciarticular disease, and polyarticular disease)
* Active synovitis
--Prior/Concurrent Therapy--
* No more than 2 concurrent nonsteroidal antiinflammatory drugs
* No more than 2 concurrent second line agents (e.g., D-penicillamine, oral or injectable gold, antimalarials, methotrexate, sulfasalazine)
* Must have started second line agent at least 3 months prior to study
* Must be on stable doses of all medications for at least 1 month prior to study
* Prior prednisone allowed if started at least 3 months prior to study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
15 Years
Study:
NCT00004420
Study Brief:
Protocol Section:
NCT00004420